The strategy change means costs will be out of whack so focus on the revenue numbers. Once this program is complete, the costs will stabilise and so will margins, meaning the NPAT will normalise.
This stock is trading at about 10x EV/EBITDA that's growing around 20% for a top quality market leading set of products. Can't say it's expensive.
- Forums
- ASX - By Stock
- CL1
- Ann: Class - FY21 Investor Presentation & CEO Commentary
Ann: Class - FY21 Investor Presentation & CEO Commentary, page-4
Featured News
Add CL1 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online